NOVO — September 2022
-
Novo lancerer billigt insulinprodukt i USA https://www.proinvestor.com/investornyt/876942/novo-lancerer-billigt-insulinprodukt-i-usa
-
Novo og Microsoft indgår digitalt samarbejde - NY
https://proinvestor.com/investornyt/877522/novo-og-microsoft-indgar-digitalt-samarbejde-ny -
Novo Nordisk fremrykker lønregulering på grund af stigende inflation
https://www.proinvestor.com/investornyt/878026/novo-nordisk-fremrykker-lonregulering-pa-grund-af-stigende-inflation -
Koden...Det er det ikke. Dækningsbidraget på produkterne er mellem 80-90%. Der er således rigeligt råd til gassen.
-
Novo står til at blive ramt af ny lovgivning i USA https://www.proinvestor.com/investornyt/880768/novo-star-til-at-blive-ramt-af-ny-lovgivning-i-usa
-
Novo-rivals diabetesmiddel kan blive største lægemiddel nogensinde https://www.proinvestor.com/investornyt/882290/novo-rivals-diabetesmiddel-kan-blive-storste-laegemiddel-nogensinde
-
Novo/Oddo: Anbefaling løftet til "outperform" fra "neutral" https://www.proinvestor.com/investornyt/884508/novo-oddo-anbefaling-loftet-til-outperform-fra-neutral-gent
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind